Sue Haupt's Publications

About Sue Haupt's Publications

Senior Research Fellow, Women’s Health Program
  • Research Associate, Women’s Health Program, UNSW
  • Honorary Senior Research Fellow, Sir Peter MacCallum Department of Oncology at UoM
  • BSc (Hons) ,
  • PhD

  • The power-and complexity-of policy to drive advances in women’s health

    Science Advances Date published:

  • Catalysing change in health and medical research policy: an Australian case study of deliberative democracy to reform sex and gender policy recommendations

    Frontiers in Public Health Date published:

  • Neglecting sex and gender in research is a public-health risk

    Nature Date published:

  • A life-course approach to tackling noncommunicable diseases in women

    Nature Medicine Date published:

  • Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes

    Cells Date published:

  • Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction

    Science Advances Date published:

  • Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss

    Cell Death & Disease Date published:

  • Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status

    Cancers Date published:

  • MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer

    Frontiers in Oncology Date published:

  • SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response thanTP53Mutation Status

    Molecular Cancer Therapeutics Date published:

  • Sex disparities matter in cancer development and therapy

    Nature Reviews Cancer Date published:

  • Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity

    Frontiers in Genetics Date published:

  • Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report

    BMC Urology Date published:

  • MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

    Breast Cancer Research Date published:

  • TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival

    Cancers Date published:

  • High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

    Journal for ImmunoTherapy of Cancer Date published: